Burling Wealth Partners’s AbbVie ABBV Stock Holding History

Burling Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.4M	Sell	49,282 -252	-0.5%	-$54.2K	1.81%	16
2026 Q1	$10.8M	Sell	49,534 -386	-0.8%	-$85.6K	1.74%	15
2025 Q4	$11.4M	Buy	49,920 +1,849	+4%	+$421K	1.77%	17
2025 Q3	$11.1M	Buy	48,071 +1,300	+3%	+$265K	1.84%	15
2025 Q2	$8.68M	Buy	46,771 +2,693	+6%	+$500K	1.6%	16
2025 Q1	$9.24M	Buy	44,078 +4,172	+10%	+$811K	1.94%	12
2024 Q4	$7.09M	Buy	+39,906	New	+$7.34M	1.45%	14

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Burling Wealth Partners's ABBV Position: Q2 2026 in Review

Burling Wealth Partners reduced its AbbVie (ABBV) stake by 0.51% in Q2 2026, selling an estimated $54.2K and leaving 49,282 shares worth $12.4M. The position accounts for 1.81% of the portfolio, ranked #16.

Burling Wealth Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Burling Wealth Partners held 49,282 shares of AbbVie worth $12.4M as of Q2 2026.
Burling Wealth Partners sold 252 AbbVie shares in Q2 2026, an estimated $54.2K.
AbbVie made up 1.81% of Burling Wealth Partners's portfolio in Q2 2026, its #16 holding.
Burling Wealth Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Burling Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.